Physician Assistant in Coushatta, LA Accepting Medicare
3 Physician Assistant nurses found. Showing 1 - 3
 Mr. Christopher Troy Bamburg, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1635 Marvel St, Coushatta, LA 71019 Phone: 318-932-2000 |
 Melanie Paul Francis, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 1635 Marvel St, Coushatta, LA 71019 Phone: 318-294-4498 |
Mr. Thomas William Coleman, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 1635 Marvel St, Coushatta, LA 71019 Phone: 318-932-2085 Fax: 318-932-2215 |
News Archive
Health Secretary and education leader commend school for encouraging physical activities among students
During a visit today to Hanover Area Junior-Senior High School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to boost physical activity among middle school students.
Psychiatrists increasingly refuse to accept private insurance as payment
Access to mental health care has become a prominent issue in Congress following mass shootings around the country. But a new study in JAMA Psychiatry, led by researchers at Weill Cornell Medical College, suggests that unless those in need of help have deep pockets, they might have a hard time finding a psychiatrist that will provide the needed services.
Ebola virus can linger in semen of some men nine months after onset of symptoms
Preliminary results of a study into persistence of Ebola virus in body fluids show that some men still produce semen samples that test positive for Ebola virus nine months after onset of symptoms.
BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine
BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2. The Phase 1 study is an open label ascending dose trial, assessing safety and immune response in healthy volunteers. The study is taking place in the UK at the Chelsea and Westminster Hospital in London and will involve up to 42 already identified subjects.
FDA clears Stryker's Trevo Pro Retriever to treat acute ischemic stroke
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
› Verified 4 days ago